Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 12, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2019. Go to the latest filing (Q3 2026)

4.6B USDQ3 2019
Total value of stock positions
4.6B USD
Positions
224
Share of the ten largest
43.7%

The ten largest positions Q3 2019

  1. Tesla, Inc. 6.2%▲ +0.8%
  2. FMS Enterprises Migun Ltd 4.8%new
  3. Block, Inc. 4.6%▲ +36.6%
  4. Illumina, Inc. 4.6%▲ +29.4%
  5. Fattal Holdings 1998 Ltd 4.3%new
  6. One Software Technologies Ltd 4.1%new
  7. Bet Shemesh Engines Holdings 1 4.1%▼ −25.7%
  8. Matrix IT Ltd 3.8%new
  9. Stratasys Ltd 3.6%▲ +1.2%
  10. Partner Communications Co Ltd 3.6%new
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q3 2019

Positions Q3 2019 per 13F filing, 50 of 83
Symbol Weight Shares Reported value Change Held since
TSLA Tesla, Inc. 6.2% 1,172,610 282.4M USD +0.8% increased Q4 2016 or earlier 12 quarters
XYZ Block, Inc. 4.6% 3,424,085 212.1M USD +36.6% increased Q4 2016 or earlier 12 quarters
ILMN Illumina, Inc. 4.6% 695,310 211.5M USD +29.4% increased Q4 2016 or earlier 12 quarters
Stratasys Ltd 3.6% 7,804,069 166.3M USD +1.2% increased Q4 2016 or earlier 12 quarters
CRISPR Therapeutics AG 2.5% 2,782,140 114.0M USD +2.1% increased Q2 2017 10 quarters
Intellia Therapeutics Inc 2.5% 8,470,576 113.1M USD +2.8% increased Q4 2016 or earlier 12 quarters
Editas Medicine Inc 2.4% 4,932,398 112.2M USD +1.7% increased Q1 2017 11 quarters
2U Inc 1.8% 5,071,776 82.6M USD +261.2% increased Q4 2016 or earlier 12 quarters
Splunk Inc 1.7% 667,462 78.7M USD +31.6% increased Q4 2016 or earlier 12 quarters
Xilinx Inc 1.7% 810,328 77.7M USD +72.2% increased Q4 2016 or earlier 12 quarters
Proto Labs Inc 1.5% 680,038 69.4M USD +44.4% increased Q4 2016 or earlier 12 quarters
LendingTree Inc 1.5% 221,461 68.7M USD +123.7% increased Q4 2016 or earlier 12 quarters
Materialise NV 1.1% 2,819,385 52.1M USD +1.0% increased Q4 2016 or earlier 12 quarters
Cerus Corp 1.0% 8,683,170 44.8M USD +2.2% increased Q4 2016 or earlier 12 quarters
Syros Pharmaceuticals Inc 0.9% 3,834,728 39.8M USD +1.1% increased Q4 2016 or earlier 12 quarters
NFLX Netflix 0.8% 141,083 37.8M USD +19.9% increased Q4 2016 or earlier 12 quarters
Compugen Ltd 0.8% 8,691,317 36.8M USD +2.3% increased Q4 2016 or earlier 12 quarters
APTV Aptiv 0.8% 395,575 34.6M USD +422.3% increased Q4 2017 8 quarters
ADSK Autodesk 0.6% 201,258 29.7M USD +512.7% increased Q4 2016 or earlier 12 quarters
Roku Inc 0.6% 289,270 29.4M USD +273.6% increased Q2 2019 2 quarters
Eventbrite Inc 0.6% 1,660,664 29.4M USD +0.8% increased Q4 2018 4 quarters
Seres Therapeutics Inc 0.6% 7,074,965 28.4M USD +0.5% increased Q4 2016 or earlier 12 quarters
MELI MercadoLibre 0.5% 37,911 20.9M USD +158.5% increased Q4 2016 or earlier 12 quarters
IOVA Iovance Biotherapeutics 0.3% 814,796 14.8M USD +0.9% increased Q1 2018 7 quarters
Arcturus Therapeutics Holdings 0.3% 1,274,413 13.1M USD +26.9% increased Q2 2019 2 quarters
Cellectis SA 0.3% 1,239,863 12.9M USD +12.4% increased Q1 2017 11 quarters
Ionis Pharmaceuticals Inc 0.3% 196,669 11.8M USD +24.7% increased Q4 2016 or earlier 12 quarters
REGN Regeneron Pharmaceuticals 0.2% 40,073 11.1M USD +40.1% increased Q4 2016 or earlier 12 quarters
Inovio Pharmaceuticals Inc 0.2% 4,222,690 8.7M USD +6.8% increased Q4 2016 or earlier 12 quarters
Codexis Inc 0.2% 630,461 8.6M USD +86.9% increased Q4 2018 4 quarters
TWLO Twilio 0.2% 66,094 7.3M USD +11.3% increased Q4 2018 4 quarters
CareDx Inc 0.2% 317,300 7.2M USD +148.7% increased Q2 2019 2 quarters
Twist Bioscience Corp 0.1% 245,627 5.9M USD +14.9% increased Q2 2019 2 quarters
Rubius Therapeutics Inc 0.1% 730,890 5.7M USD +4.7% increased Q3 2018 5 quarters
Fate Therapeutics Inc 0.1% 339,039 5.3M USD +52.7% increased Q2 2019 2 quarters
Cellular Biomedicine Group Inc 0.1% 349,625 5.2M USD +11.2% increased Q1 2019 3 quarters
Guardant Health Inc 0.1% 74,203 4.7M USD +0.2% increased Q2 2019 2 quarters
Personalis Inc < 0.1% 299,464 4.4M USD +51.5% increased Q2 2019 2 quarters
JD JD.com (ADR) < 0.1% 150,755 4.3M USD +2.3% increased Q3 2017 9 quarters
WDAY Workday, Inc. < 0.1% 15,131 2.6M USD +16,346.7% increased Q4 2017 8 quarters
Guidewire Software Inc < 0.1% 21,911 2.3M USD +22.3% increased Q4 2017 8 quarters
Rakuten Inc < 0.1% 233,205 2.3M USD +5.6% increased Q4 2017 8 quarters
INTU Intuit < 0.1% 8,549 2.3M USD +2.9% increased Q2 2017 10 quarters
LINE Corp < 0.1% 80,154 2.3M USD +6.4% increased Q1 2019 3 quarters
3D Systems Corp < 0.1% 246,937 2.0M USD +9.2% increased Q4 2016 or earlier 12 quarters
ICE Intercontinental Exchange < 0.1% 21,364 2.0M USD +37.7% increased Q1 2018 7 quarters
SBI Holdings Inc/Japan < 0.1% 89,800 1.9M USD +5.2% increased Q4 2017 8 quarters
HDFC Bank Ltd < 0.1% 27,516 1.6M USD +252.5% increased Q4 2017 8 quarters
IBKR Interactive Brokers < 0.1% 28,010 1.5M USD +4.1% increased Q4 2017 8 quarters
Adyen NV < 0.1% 2,212 1.4M USD +29.2% increased Q1 2019 3 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 largest of 83 positions.

Breakdown by sector

  • Consumer Discretionary 7.3%
  • Technology 6.4%
  • Health Care 5.8%
  • Financials 4.9%
  • Communication Services 1.0%
  • Industrials < 0.1%
  • not in our coverage 74.5%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close